175 related articles for article (PubMed ID: 10838494)
1. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma.
Okusaka T; Okada S; Ueno H; Ikeda M; Yoshimori M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Iwata R; Furukawa H; Moriyama N; Sakamoto M; Hirohashi S
Oncology; 2000 May; 58(4):293-9. PubMed ID: 10838494
[TBL] [Abstract][Full Text] [Related]
2. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
Takekoshi H; Oyama R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the therapeutic effect of TAE on primary liver cancer.
Yamada T; Makita F; Takehara K; Saitou S; Satou K; Endou K; Shimoda R; Matsuzaki Y; Matsumoto T; Yuasa K
Cancer Chemother Pharmacol; 1994; 33 Suppl():S55-9. PubMed ID: 7511068
[TBL] [Abstract][Full Text] [Related]
4. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI].
Shimizu T; Endou H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693
[TBL] [Abstract][Full Text] [Related]
5. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.
Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919
[TBL] [Abstract][Full Text] [Related]
6. Use of fructose 1,6-diphosphate aldolase to detect tumour necrosis after transcatheter arterial embolization of hepatocellular carcinoma.
Khan KN; Nakata K; Kusumoto Y; Nakao K; Kato Y; Nagataki S
J Gastroenterol Hepatol; 1998 Feb; 13(2):192-6. PubMed ID: 10221823
[TBL] [Abstract][Full Text] [Related]
7. Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis.
Kishi K; Sonomura T; Mitsuzane K; Nishida N; Kimura M; Satoh M; Yamada R; Kodama N; Kinoshita M; Tanaka H
Radiat Med; 1992; 10(5):189-95. PubMed ID: 1279748
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.
Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M
Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681
[TBL] [Abstract][Full Text] [Related]
9. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
10. [Immunochemo-embolization therapy of hepatocellular carcinoma].
Takekoshi H
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1916-9. PubMed ID: 1715155
[TBL] [Abstract][Full Text] [Related]
11. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
Higuchi T; Kikuchi M; Okazaki M
Cancer; 1994 May; 73(9):2259-67. PubMed ID: 7513245
[TBL] [Abstract][Full Text] [Related]
14. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
15. [Transcatheter arterial embolization of hepatocellular carcinoma using CO2-US].
Miyajima Y; Sakaguchi S; Tohara K
Nihon Rinsho; 1998 Apr; 56(4):990-3. PubMed ID: 9577622
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.
Ohishi H; Uchida H; Yoshimura H; Ohue S; Ueda J; Katsuragi M; Matsuo N; Hosogi Y
Radiology; 1985 Jan; 154(1):25-9. PubMed ID: 2981114
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma].
Kanno T; Harihara S; Kim K; Kimura S; Tamori A; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T; Nakamura K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):683-7. PubMed ID: 2451472
[TBL] [Abstract][Full Text] [Related]
18. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma].
Ihaya T; Ametani M; Matsusue E
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698
[TBL] [Abstract][Full Text] [Related]
19. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
20. [Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol].
Mlinarić B
Lijec Vjesn; 2000; 122(1-2):6-8. PubMed ID: 10916349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
